Nearly a decade after spinning out its Chinese research hub to form Dizal Pharmaceutical, AstraZeneca is paying up to $1.5 billion to buy a piece of the pipeline, securing exclusive global rights for ...
Bristlemoon Global Fund analyzes ASML's valuation and growth potential amid a semiconductor capital equipment supercycle.
Shares of Dizal Pharmaceutical surged by their daily trading limit after the Chinese drugmaker granted AstraZeneca the ...
BP flags lower second-quarter production but expects stronger oil price realisations, while AstraZeneca agrees a lung cancer licensing deal with Dizal Pharmaceutical worth up to USD1.5 billion. Also, ...
Go Digit General Insurance Limited is an India-based general insurance company. The Company is engaged in property and casualty insurance and reinsurance and the associated investment management. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results